Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 2.47% is 74% below its 5-year average of 9.64%, near the high end of its 5-year range (-82.77%–25.70%).
15.89% below its 12-month average of 2.94%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 2.22%.
OPERATING MARGIN
2.47%
OPERATING MARGIN AVG TTM
2.94%
OPERATING MARGIN AVG 3Y
8.79%
OPERATING MARGIN AVG 5Y
9.64%
OPERATING MARGIN AVG 10Y
5.69%
OPERATING MARGIN AVG 15Y
0.87%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-15.89%
CURRENT VS 3Y AVG
-71.90%
CURRENT VS 5Y AVG
-74.39%
CURRENT VS 10Y AVG
-56.56%
CURRENT VS 15Y AVG
+183.76%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pacira BioSciences, Inc.
Market Cap
$973.15M
Operating Margin
2.47%
TTM Avg
2.94%
3Y Avg
8.79%
5Y Avg
9.64%
Market Cap
$968.25M
Operating Margin
-1149.52%
TTM Avg
-2324.93%
3Y Avg
-1162.47%
5Y Avg
-1162.47%
Market Cap
$981.89M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$983.53M
Operating Margin
-33.86%
TTM Avg
-38.38%
3Y Avg
-66.13%
5Y Avg
-173.51%
Market Cap
$984.44M
Operating Margin
-130.20%
TTM Avg
-311.82%
3Y Avg
-583.08%
5Y Avg
-487.88%
Market Cap
$943.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$990.42M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$999.19M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | $973.15M | 2.47% | 2.94% | 8.79% | 9.64% |
| Aktis Oncology, Inc. (AKTS)vs › | $968.25M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $981.89M | 0.00% | 0.00% | 0.00% | 0.00% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $983.53M | -33.86% | -38.38% | -66.13% | -173.51% |
| MeiraGTx Holdings plc (MGTX)vs › | $984.44M | -130.20% | -311.82% | -583.08% | -487.88% |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $943.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Savara Inc. (SVRA)vs › | $950.86M | 0.00% | 0.00% | 0.00% | -3197.15% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $990.42M | N/A | N/A | N/A | N/A |
| Vor Biopharma Inc. (VOR)vs › | $999.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kura Oncology, Inc. (KURA)vs › | $937.68M | -449.94% | -404.25% | -202.12% | -134.75% |
Gross Margin
79.2%
Operating Margin
2.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 2.22% |
| 2026-03-31 | 2.61% |
| 2025-12-31 | 1.62% |
| 2025-09-30 | 3.54% |
| 2025-06-30 | 4.69% |
| 2025-03-31 | 1.18% |
| 2024-12-31 | 13.19% |
| 2024-09-30 | -82.77% |
| 2024-06-30 | 15.86% |
| 2024-03-31 | 7.91% |
| 2023-12-31 | 18.30% |
| 2023-09-30 | 10.81% |
| 2023-06-30 | 23.53% |
| 2023-03-31 | -1.93% |
| 2022-12-31 | -5.75% |
| 2022-09-30 | 12.71% |
| 2022-06-30 | 18.44% |
| 2022-03-31 | 11.01% |
| 2021-12-31 | 2.65% |
| 2021-09-30 | 24.61% |
| 2021-06-30 | 25.70% |
| 2021-03-31 | 16.33% |
| 2020-12-31 | 14.34% |
| 2020-09-30 | 15.00% |
| 2020-06-30 | -9.47% |
| 2020-03-31 | 16.17% |
| 2019-12-31 | 1.40% |
| 2019-09-30 | 2.31% |
| 2019-06-30 | 5.14% |
| 2019-03-31 | 1.18% |
| 2018-12-31 | 12.89% |
| 2018-09-30 | 4.85% |
| 2018-06-30 | 7.78% |
| 2018-03-31 | -9.30% |
| 2017-12-31 | 10.70% |
| 2017-09-30 | -5.30% |
| 2017-06-30 | -22.25% |
| 2017-03-31 | -20.28% |
| 2016-12-31 | -3.38% |
| 2016-09-30 | -30.52% |
| 2016-06-30 | -9.25% |
| 2016-03-31 | -3.44% |
| 2015-12-31 | -1.17% |
| 2015-09-30 | 8.21% |
| 2015-06-30 | 3.07% |
| 2015-03-31 | 5.73% |
| 2014-12-31 | 12.82% |
| 2014-09-30 | -1.89% |
| 2014-06-30 | -6.03% |
| 2014-03-31 | -25.25% |
| 2013-12-31 | -29.25% |
| 2013-09-30 | -55.09% |
| 2013-06-30 | -70.07% |
| 2013-03-31 | -160.91% |
| 2012-12-31 | -151.47% |
| 2012-09-30 | -185.08% |
| 2012-06-30 | -53.68% |
| 2012-03-31 | -142.71% |
| 2011-12-31 | -347.67% |
| 2011-09-30 | -220.75% |
| 2011-06-30 | -234.63% |
| 2011-03-31 | -184.36% |
| 2010-12-31 | -259.24% |
| 2010-09-30 | -142.34% |
| 2010-06-30 | -184.22% |
| 2010-03-31 | -96.47% |
| 2009-12-31 | -182.31% |
| 2009-09-30 | -162.77% |
